254 related articles for article (PubMed ID: 35655918)
1. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway.
Wang B; Wang Y; Wang X; Gu J; Wu W; Wu H; Wang Q; Zhou D
Dis Markers; 2022; 2022():5762686. PubMed ID: 35655918
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
[TBL] [Abstract][Full Text] [Related]
3. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.
Zhu T; Hu Z; Wang Z; Ding H; Li R; Wang J; Wang G
Cell Biol Toxicol; 2023 Oct; 39(5):1923-1937. PubMed ID: 35246762
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
5. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicle-Mediated miR-150-3p Delivery in Joint Homeostasis: A Potential Treatment for Osteoarthritis?
Wang H; Shu J; Zhang C; Wang Y; Shi R; Yang F; Tang X
Cells; 2022 Sep; 11(17):. PubMed ID: 36078172
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis.
Li WJ; Xie XX; Bai J; Wang C; Zhao L; Jiang DQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8374-8382. PubMed ID: 30556878
[TBL] [Abstract][Full Text] [Related]
11. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
12. Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1.
Tao S; Li H; Ma X; Ma Y; He J; Gao Y; Li J
Cancer Gene Ther; 2021 Jun; 28(6):634-648. PubMed ID: 33154575
[TBL] [Abstract][Full Text] [Related]
13. HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma.
Liu S; Dou L; Miao M; Man X; Wei B; Jiang Z; Ouyang Y; Ozaki T; Yu M; Zhu Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):72. PubMed ID: 36973704
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression.
Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X
FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery.
Tao S; Wang J; Li F; Shi B; Ren Q; Zhuang Y; Qian X
FASEB J; 2024 Jan; 38(2):e23165. PubMed ID: 38197195
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-mediated delivery of miR-127-3p inhibits the proliferation and invasion of choriocarcinoma cells by targeting ITGA6.
Ma H; Weng F; Wang L; Tong X; Yao Y; Li H
Exp Cell Res; 2022 May; 414(2):113098. PubMed ID: 35288170
[TBL] [Abstract][Full Text] [Related]
19. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
Huang S; Li Y; Wu P; Xiao Y; Duan N; Quan J; Du W
J Cell Mol Med; 2020 Oct; 24(19):11512-11523. PubMed ID: 32871042
[TBL] [Abstract][Full Text] [Related]
20. Periodontitis-compromised dental pulp stem cells secrete extracellular vesicles carrying miRNA-378a promote local angiogenesis by targeting Sufu to activate the Hedgehog/Gli1 signalling.
Zhou H; Li X; Wu RX; He XT; An Y; Xu XY; Sun HH; Wu LA; Chen FM
Cell Prolif; 2021 May; 54(5):e13026. PubMed ID: 33759282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
